跳至主要内容
临床试验/NCT00714740
NCT00714740已完成4 期

Treatment of Patients With the Obstructive Sleep Apnea Syndrome at Altitude

University of Zurich2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2008年6月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
49
试验地点
2
主要终点
sleep disordered breathing, sleep structure, vigilance, subjective sleep quality acute mountain sickness

研究概览

简要总结

The purpose of the study is to investigate the effect of acetazolamide as a treatment for sleep related breathing disturbances in patients with the obstructive sleep apnea syndrome living at low altitude during a sojourn at moderate altitude

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Obstructive sleep apnea syndrome, successfully on CPAP therapy
  • Residence at low altitude (<800m)
  • Obstructive apnea/hypopnea index >20/h and a complaint of excessive daytime sleepiness before introduction of CPAP therapy.
  • >15 oxygen desaturations/h (>3% dips) during an ambulatory nocturnal pulse oximetry performed at the end of a 4-night period without CPAP

排除标准

  • Sleep disorders other than OSA.
  • More than mild cardiovascular disease, unstable or recently diagnosed (within the last 6 months) cardiovascular disease such as arterial hypertension, coronary artery or cerebrovascular disease.
  • Any lung disease, pulmonary hypertension.
  • Chronic rhinitis.
  • Treatment with drugs that affect respiratory center drive (benzodiazepines or other sedatives or sleep inducing drugs, morphine or codeine derivates), stimulants (modafinil, methylphenidate, theophylline)
  • Internal, neurologic or psychiatric disease that interfere with sleep quality.
  • Previous intolerance to moderate or low altitude (<2600m).
  • Exposure to altitudes >1500m for >1 day within the last 4 weeks before the study

结局指标

主要结局

sleep disordered breathing, sleep structure, vigilance, subjective sleep quality acute mountain sickness

时间窗: during treatment while at altitude

次要结局

  • blood pressure endothelial function(during treatment while at altitude)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验